Acadia Healthcare Company, Inc.
ACHC · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $3,153,963 | $2,928,738 | $2,610,399 | $2,314,394 |
| % Growth | 7.7% | 12.2% | 12.8% | – |
| Cost of Goods Sold | $2,441,981 | $2,246,129 | $100,200 | $90,702 |
| Gross Profit | $711,982 | $682,609 | $2,510,199 | $2,223,692 |
| % Margin | 22.6% | 23.3% | 96.2% | 96.1% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $189,706 | $176,013 | $1,596,909 | $1,419,062 |
| SG&A Expenses | $189,706 | $176,013 | $1,596,909 | $1,419,062 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $445,595 | $390,156 |
| Operating Expenses | $189,706 | $176,013 | $2,042,504 | $1,809,218 |
| Operating Income | $522,276 | $506,596 | $467,695 | $414,474 |
| % Margin | 16.6% | 17.3% | 17.9% | 17.9% |
| Other Income/Exp. Net | -$180,397 | -$531,956 | -$93,552 | -$138,714 |
| Pre-Tax Income | $341,879 | -$25,360 | $374,143 | $275,760 |
| Tax Expense | $77,395 | -$9,699 | $94,110 | $67,557 |
| Net Income | $255,612 | -$21,667 | $273,139 | $190,635 |
| % Margin | 8.1% | -0.7% | 10.5% | 8.2% |
| EPS | 2.79 | -0.24 | 3.05 | 2.15 |
| % Growth | 1,262.5% | -107.9% | 41.9% | – |
| EPS Diluted | 2.78 | -0.24 | 2.98 | 2.1 |
| Weighted Avg Shares Out | 91,621 | 90,949 | 89,680 | 88,769 |
| Weighted Avg Shares Out Dil | 92,059 | 90,949 | 91,555 | 90,793 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $116,368 | $82,125 | $69,760 | $76,993 |
| Depreciation & Amortization | $149,595 | $132,349 | $117,769 | $106,717 |
| EBITDA | $607,842 | $189,114 | $561,672 | $459,470 |
| % Margin | 19.3% | 6.5% | 21.5% | 19.9% |